A Toronto-based biotech company is studying a psychedelic drug based on DMT as a treatment for Alzheimer’s disease with a Phase ll clinical trial in Argentina.
September 21, 2022
Could dementia and Alzheimer's patients benefit from cannabis?
February 28, 2020
Researches will test the effectiveness of CogniCann, a proprietary oral cannabis spray, as a treatment for aggression and agitation caused by dementia.
October 1, 2019
On July 1, Alzheimer's patients can begin registering for Minnesota's medical cannabis program. Registered patients can purchase cannabis starting August 1.
July 1, 2019
Researchers conducted the first clinical trial of the popular synthetic THC drug nabilone on people with Alzheimer's.
July 25, 2018
Alzheimer's patients in Puerto Rico may get cannabis-based treatment to better cope with the symptoms of the illness.
March 28, 2018
A preclinical study published in the Journal of Alzheimer’s Disease found that very small doses of tetrahydrocannabinol (THC), can slow the production of…
June 1, 2017